MERGEMEIER STEFFEN has a total of 16 patent applications. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology and pharmaceuticals are SHANGHAI TISSUEBANK BIOTECHNOLOGY CO LTD, JUMPCODE GENOMICS INC and GUANGZHOU HEAS BIOTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | United States | 4 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Mergemeier Steffen | 16 |
Publication | Filing date | Title |
---|---|---|
WO2016012508A1 | Method for the detection of sepsis | |
EP2617836A1 | Method for detecting a methicillin resistant coagulase positive Staphylococcus aureus strain | |
US2013029340A1 | Method for detecting more than one target in a pcr-based approach applying an un-specific dye which is not interfering with the emission of fluorophore-labeled probes | |
EP2465934A1 | Extraction of nucleic acids | |
WO2010054858A2 | Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens | |
EP2256215A1 | Assay system using a nuclease activity of a nucleic acid polymerase |